pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,396 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 10 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×clear all
type
  • approval18,987
  • device 510k5,000
  • phase readout4,876
  • grant4,728
  • 8k filing2,396
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings295
  • therapy area
    • Ophthalmology5

    Week of Apr 27, 1998

    1
    ›May 1, 1998approval10312d agoSUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approvalsufentanil citrate

    Sponsor: RISING. Form: INJECTABLE. Route: INJECTION

    full page →sufentanil citrate →fda approvals ↗

    Week of May 4, 1998

    7
    ›May 5, 1998approval10308d agoNALBUPHINE HYDROCHLORIDE — FDA approvalNALBUPHINE HYDROCHLORIDE

    Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →NALBUPHINE HYDROCHLORIDE →fda approvals ↗
    ›May 5, 1998approval10308d agoNALBUPHINE HYDROCHLORIDE — FDA approvalNALBUPHINE HYDROCHLORIDE

    Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →NALBUPHINE HYDROCHLORIDE →fda approvals ↗
    ›May 6, 1998approval10307d agoPHENERGAN W/ CODEINE (CODEINE PHOSPHATE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›May 7, 1998approval10306d agoLIDOCAINE HYDROCHLORIDE — FDA approvalLaryng-O-Jet

    Sponsor: COSETTE. Form: JELLY. Route: TOPICAL

    full page →Laryng-O-Jet →fda approvals ↗
    ›May 8, 1998approval10305d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›May 8, 1998approval10305d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›May 8, 1998approval10305d agoPRED MILD (PREDNISOLONE ACETATE) — FDA approvalprednisolone acetate

    Sponsor: ABBVIE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

    full page →prednisolone acetate →fda approvals ↗

    Week of May 11, 1998

    3
    ›May 11, 1998approval10302d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›May 12, 1998approval

    Week of May 18, 1998

    1
    ›May 20, 1998approval10293d agoFIORICET W/ CODEINE (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: ACTAVIS LABS UT INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗

    Week of May 25, 1998

    13
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval

    Week of Jun 8, 1998

    6
    ›Jun 9, 1998approval10273d agoLOPROX (CICLOPIROX) — FDA approvalATLAS Molecular Pharma SL

    Sponsor: EUROFARMA. Form: SUSPENSION. Route: TOPICAL

    full page →fda approvals ↗
    ›Jun 10, 1998approval

    Week of Jun 15, 1998

    1
    ›Jun 17, 1998approval10265d agoCEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗

    Week of Jun 22, 1998

    3
    ›Jun 22, 1998approval10260d agoPRIFTIN (RIFAPENTINE) — FDA approvalrifapentine

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →rifapentine →fda approvals ↗
    ›Jun 23, 1998approval

    Week of Jun 29, 1998

    1
    ›Jun 30, 1998approval10252d agoLUPRON DEPOT-PED KIT (LEUPROLIDE ACETATE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗

    Week of Jul 6, 1998

    2
    ›Jul 8, 1998approval10244d agoOPILL (NORGESTREL) — FDA approvalHRA Pharma LLC

    Sponsor: LABORATOIRE HRA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jul 9, 1998approval

    Week of Jul 13, 1998

    12
    ›Jul 15, 1998approval10237d agoLANOXIN PEDIATRIC (DIGOXIN) — FDA approvalDIGOXIN

    Sponsor: AZURITY. Form: INJECTABLE. Route: INJECTION

    full page →DIGOXIN →fda approvals ↗
    ›Jul 15, 1998approval
    ← prev
    page 54 of 380
    next →
    10301d ago
    FOSAMAX (ALENDRONATE SODIUM) — FDA approvalALENDRONATE SODIUM

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›May 14, 1998approval10299d agoPROMETRIUM (PROGESTERONE) — FDA approvalIBSA Institut Biochimique SA

    Sponsor: ACERTIS PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    10287d ago
    LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›May 26, 1998approval10287d agoSUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approvalsufentanil citrate

    Sponsor: RISING. Form: INJECTABLE. Route: INJECTION

    full page →sufentanil citrate →fda approvals ↗
    ›May 29, 1998approval10284d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: TABLET. Route: ORAL

    full page →METHADONE HYDROCHLORIDE →fda approvals ↗
    ›May 29, 1998approval10284d agoUNASYN (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    10272d ago
    SINEMET CR (CARBIDOPA) — FDA approvalcarbidopa

    Sponsor: ORGANON LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →carbidopa →fda approvals ↗
    ›Jun 11, 1998approval10271d agoVALPROIC ACID — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Jun 12, 1998approval10270d agoCEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗
    ›Jun 12, 1998approval10270d agoCEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗
    ›Jun 12, 1998approval10270d agoDEXEDRINE SPANSULE (DEXTROAMPHETAMINE SULFATE) — FDA approvalMallinckrodt LLC

    Sponsor: IMPAX LABS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    10259d ago
    METHYLPREDNISOLONE — FDA approvalMEDROL

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →MEDROL →fda approvals ↗
    ›Jun 23, 1998approval10259d agoHALDOL (HALOPERIDOL DECANOATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    10243d ago
    CARTIA XT (DILTIAZEM HYDROCHLORIDE) — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    10237d ago
    TEGRETOL-XR (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL-XR (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL-XR (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL-XR (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Jul 15, 1998approval10237d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    $ANIP78.53+1.19%
    $AMRX17.97+1.24%
    $IGC0.2670+0.41%
    $ABBV256.92+1.43%
    $ABBV256.92+1.43%
    $ABBV256.92+1.43%
    $PYPD4.2400+6.00%
    $OGN13.55-0.07%
    $PFE24.66+0.35%
    $OGN13.55-0.07%
    $NVS156.14+2.00%
    $ANIP78.53+1.19%
    $NVS156.14+2.00%
    $NVS156.14+2.00%
    $NVS156.14+2.00%
    $NVS156.14+2.00%
    $NVS156.14+2.00%
    $NVS156.14+2.00%
    $NVS156.14+2.00%
    $NVS156.14+2.00%
    $NVS156.14+2.00%
    $NVS156.14+2.00%